HKA 12-year-old boy named Zou Weiluo from Shanghai, who was diagnosed with spinal muscular atrophy (SMA) at seven months, recently graduated from primary school despite doctors initially predicting he would not live past the age of three. His family's dedicated care allowed him to survive and improve his physical abilities, including moving his fingers and flexing his elbows. The availability of SMA treatment in China, which was previously prohibitively expensive, became more affordable after being included in the national medical insurance scheme in 2021. During his graduation ceremony, classmates honored him as a 'little warrior' for his bravery, highlighting his resilience against the disease.
Bias read (Center): The article focuses on a personal health story with broader implications regarding healthcare access and policy changes in China. While the subject matter involves government action (national medical insurance), the framing remains neutral, presenting both the challenge faced by the individual and a
